𝔖 Bobbio Scriptorium
✦   LIBER   ✦

60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center || Acute Myeloid Leukemia

✍ Scribed by Rodriguez, M. Alma; Walters, Ronald S.; Burke, Thomas W.


Book ID
121399507
Publisher
Springer New York
Year
2012
Tongue
English
Weight
256 KB
Edition
2013
Category
Article
ISBN
1461451973

No coin nor oath required. For personal study only.

✦ Synopsis


This unique book provides a retrospective analysis of the changes in survival outcomes at the University of Texas, M.D. Anderson Cancer Center over the past six decades. Since opening its doors in 1944, M.D. Anderson has kept a continuous, uninterrupted data repository of the treatment and outcomes of each of its patients. It is this visionary database from the center’s tumor registry which makes this groundbreaking book possible. Tracking results across time, this book shows radical shifts in outcomes trends, where great progress has been made, and where there is still a long way to go, and offers a snapshot into the parallel history of developments in care. Such data is crucial to informing how patients are counseled, how treatment decisions are determined, and how prognoses are made. 60 Years of Survival Outcomes at the University of Texas, M.D. Anderson Cancer Center is the only book to concurrently present longitudinal data on survival outcomes across the spectrum of rare and common cancers. Each chapter deals with a specific disease site, discussing current management approaches and presenting key data replete with illustrative charts, graphs, and tables. With the resources available only to the practitioners at this inimitable institution, this book heralds a cornerstone moment in the study of survival outcomes and the depth of our knowledge of cancer care.


πŸ“œ SIMILAR VOLUMES


Long-term follow-up of patients with new
✍ Elihu Estey; Marcos deLima; Sara Strom; Sherry Pierce; Emil J Freireich; Michael πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 3 views

## RESULTS. Because failure rates declined to relatively low levels after a first or later complete remission of Β’3 years' duration, such patients comprised a ''potentially Departments of Hematology and Epidemiology, cured'' cohort. The criterion for entry into this cohort was fulfilled by 215 pat